Avenue Therapeutics Inc.
1.91
0.03 (1.60%)
At close: Jan 15, 2025, 12:16 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -14.54M -8.04M -3.74M -5.21M -26.27M -21.82M -11.42M -2.38M -4.84M
Interest Income 126.00K 20.00K 7.00K 62.00K 357.00K 93.00K 88.00K n/a n/a
Pretax Income -10.49M -3.60M -3.73M -5.15M -25.91M -21.55M -12.26M -3.18M -5.23M
Net Income -10.38M 2.05M -3.72M -5.09M -25.55M -21.28M -12.26M -3.18M -5.23M
Selling & General & Admin 4.18M 5.34M 2.48M 2.35M 3.07M 4.12M 3.62M 997.00K 842.00K
Research & Development 10.36M 2.70M 1.25M 2.87M 23.19M 17.70M 7.80M 1.38M 4.00M
Other Expenses n/a n/a n/a n/a n/a 175.00K -99.00K n/a n/a
Operating Expenses 14.54M 8.04M 3.74M 5.21M 26.27M 21.82M 11.42M 2.38M 4.84M
Interest Expense n/a 1.16M n/a n/a n/a n/a 375.00K 612.00K 417.82K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a -76.55K
Cost & Expenses 14.54M 8.04M 3.74M 5.21M 26.27M 21.82M 11.42M 2.38M 4.84M
Income Tax n/a -5.65M -7.00K -62.00K -357.00K -268.00K 287.00K -1.76M -5.28M
Shares Outstanding (Basic) 141.00K 2.19M 1.13M 1.10M 1.05M 682.61K 442.33K 589.43K 556.10K
Shares Outstanding (Diluted) 141.22K 2.19M 1.13M 1.10M 1.05M 682.61K 442.33K 589.43K 556.10K
EPS (Basic) -73.6 0.94 -3.29 -4.62 -24.38 -31.17 -27.71 -5.39 -9.4
EPS (Diluted) -73.48 0.94 -3.29 -4.62 -24.38 -31.17 -27.71 -5.39 -9.4
EBITDA 4.05M n/a n/a -5.21M n/a n/a n/a -188.00K 440.27K
Depreciation & Amortization 14.54M 8.04M 3.74M 5.21M 26.27M 21.82M 11.42M 2.38M 5.28M

Create Price Alert on ATXI

Your price alert will notify you when the stock price is above 1.91.

Add to Watchlist